Foraviset Ltd. is a privately held, innovative pharmaceutical company dedicated to developing its proprietary drug, Raviset®, aimed at treating women suffering from pathological menstrual complications such as endometriosis, dysmenorrhea, and abnormal uterine bleeding (AUB). Endometriosis, which, according to the World Health Organization (WHO), affects up to 10% of women of reproductive age globally , is often underdiagnosed and presents significant treatment challenges for the medical community. There is an urgent need for a highly effective and safe therapy for endometriosis and other severe menstrual conditions. Raviset®, utilizing a novel mechanism of action, has emerged as a breakthrough therapy meeting this critical need.

Foraviset

Org chart

Teams

Offices